cdmo.directory
← Compare landing

RoslinCT vs SCTbio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/roslinct/sctbio

CategoryRoslinCTSCTbio
Listed sitecdmocdmo
SummaryRoslinCT is a cell and gene therapy CDMO offering cGMP iPSC banking, process and analytical development, and clinical and commercial manufacturing for autologous and allogeneic programs.SCTbio is a European cell and gene therapy CDMO offering cGMP manufacturing, lentiviral and gammaretroviral vector production, analytical development, and QP batch release. Its facilities include 420 m² of Class A/B/C GMP cleanrooms, and it reports more than 2,000 GMP batches manufactured.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell-Line Development
  • CMC Analytical Development
  • Process Development
  • Technology Transfer
  • Quality Control Testing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • Viral Vector Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • Process Development
  • Technology Transfer
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.
  • Oncology
Locations
  • Boston facility, Boston, Massachusetts, United States
  • Global Headquarters & EU Business Office, Prague, Praha, Czech Republic
  • US Business Office, Boston, MA, USA
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.